🕵️ BEAM Therapeutics Inc. ($BEAM)
SEC insider & ownership activity, last 12 months · CIK 1745999 · every row links its SEC filing
Over the last 12 months insiders sold $20.8M with no open-market buying against it. FMR LLC sold $11.0M (Jul–Jun). 1 planned sale is pending, the largest $887K (John M Evans). No red-flag 8-Ks in the window.
🚨 4 signals active —
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 7 sellers, $20.8M (34 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| FMR LLC | 0 | – | 4 | $11.0M | Jun 26, 2026 |
| John M. Evans | 0 | – | 13 | $6.3M | Jun 30, 2026 |
| Ciaramella Giuseppe | 0 | – | 2 | $1.4M | Apr 1, 2026 |
| Christine Bellon | 0 | – | 7 | $881K | Apr 1, 2026 |
| Simon Amy | 0 | – | 3 | $607K | Jul 27, 2026 |
| Bethany J. Cavanagh | 0 | – | 4 | $399K | Apr 1, 2026 |
| Emany Sravan Kumar | 0 | – | 1 | $171K | Dec 31, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| FMR LLC | 12.6% | 13G | Feb 5, 2026 | filing ↗ | |
| Abigail P. Johnson | 12.6% | 13G | Feb 5, 2026 | filing ↗ | |
| ARK Investment Management LLC | 12.3% | 13G | Feb 3, 2026 | filing ↗ | |
| Catherine D. Wood | 12.3% | 13G | Feb 3, 2026 | filing ↗ | |
| Joshua J. Dapice | 10.0% | 13G | Feb 5, 2026 | filing ↗ | |
| Dreyfuss, Philip D. | 10.0% | 13G | Feb 5, 2026 | filing ↗ | |
| Hannah E. Dunn | 10.0% | 13G | Feb 5, 2026 | filing ↗ | |
| Gehani, Varun N. | 10.0% | 13G | Feb 5, 2026 | filing ↗ | |
| Giauque, Nicolas | 10.0% | 13G | Feb 5, 2026 | filing ↗ | |
| Husen, Avner A. | 10.0% | 13G | Feb 5, 2026 | filing ↗ | |
| KIM, David T. | 10.0% | 13G | Feb 5, 2026 | filing ↗ | |
| LINN, Michael G. | 10.0% | 13G | Feb 5, 2026 | filing ↗ | |
| LUO Patrick (CHENG) | 10.0% | 13G | Feb 5, 2026 | filing ↗ | |
| Roberts, JR., Thomas G. | 10.0% | 13G | Feb 5, 2026 | filing ↗ | |
| Edric C. Saito | 10.0% | 13G | Feb 5, 2026 | filing ↗ | |
| Daniel S. Short | 10.0% | 13G | Feb 5, 2026 | filing ↗ | |
| Spokes, Andrew J. M. | 10.0% | 13G | Feb 5, 2026 | filing ↗ | |
| Warren, JOHN R. | 10.0% | 13G | Feb 5, 2026 | filing ↗ | |
| Wehrly, MARK C. | 10.0% | 13G | Feb 5, 2026 | filing ↗ | |
| Farallon Partners, L.L.C. | 9.7% | 13G | Feb 5, 2026 | filing ↗ | |
| ARK Investment Management LLC | 7.9% | 13G | Jan 10, 2025 | filing ↗ | |
| Blackrock, Inc. | 7.5% | 13G | Apr 17, 2025 | filing ↗ | |
| Farallon Healthcare Partners Master, L.P. | 6.0% | 13G | Feb 5, 2026 | filing ↗ | |
| Farallon Healthcare Partners (GP), L.L.C. | 6.0% | 13G | Feb 5, 2026 | filing ↗ | |
| State Street Corporation | 5.2% | 13G | Feb 9, 2026 | filing ↗ | |
| Vanguard Capital Management | 5.0% | 13G | Apr 29, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Amy Simon | $429K | Jul 27, 2026 | filing ↗ |
| John M Evans | $858K | Jun 30, 2026 | filing ↗ |
| John M Evans | $887K | Jun 29, 2026 | filing ↗ |
| Carole Ho | $2.7M | Apr 14, 2026 | filing ↗ |
| Christine Bellon | $438K | Apr 2, 2026 | filing ↗ |
| Giuseppe Ciaramella | $575K | Apr 2, 2026 | filing ↗ |
| Amy Simon | $438K | Apr 2, 2026 | filing ↗ |
| John M. Evans | $1.5M | Apr 2, 2026 | filing ↗ |
| John M Evans | $569K | Mar 31, 2026 | filing ↗ |
| John M Evans | $559K | Mar 30, 2026 | filing ↗ |
| Giuseppe Ciaramella | $1.1M | Feb 24, 2026 | filing ↗ |
| John M Evans | $709K | Jan 30, 2026 | filing ↗ |
| John M Evans | $735K | Jan 29, 2026 | filing ↗ |
| Christine Bellon | $47K | Jan 22, 2026 | filing ↗ |
| Christine Bellon | $645K | Jan 15, 2026 | filing ↗ |
| John M Evans | $616K | Oct 2, 2025 | filing ↗ |
| John M Evans | $613K | Oct 1, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Shareholder vote (5.07) | Jun 3, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Agreement terminated (1.02) | Mar 2, 2026 | filing ↗ |
| Material agreement (1.01) | Feb 24, 2026 | filing ↗ |
| Earnings (2.02) | Feb 24, 2026 | filing ↗ |
| New financial obligation (2.03) | Feb 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 24, 2026 | filing ↗ |
| Material agreement (1.01) | Feb 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 9, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 31, 2026 | filing ↗ |
| Earnings (2.02) | Jan 11, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 11, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | Dec 8, 2025 | filing ↗ |
| Earnings (2.02) | Nov 4, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 4, 2025 | filing ↗ |
| Earnings (2.02) | Aug 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 5, 2025 | filing ↗ |